Report cover image

Mice Model Market by Model Type (Inbred, Outbred, Hybrid), Service (Breeding, Rederivation), Application (Personalized Medicine), Technology (Microinjection, CRISPR/Cas9), Therapeutic Area (Oncology, Neurology), End User (CROs) - Global Forecast to 2030

Publisher MarketsandMarkets
Published Aug 12, 2025
Length 446 Pages
SKU # MKMK20306703

Description

The mice model market is projected to reach USD 2.74 billion by 2030 from USD 1.70 billion in 2025, at a CAGR of 10.0% during the forecast period. The growth of this market is driven by several factors, such as rising adoption of mice models in preclinical studies due to genetic & physiological versatility; the increasing demand for mouse clinical trials (MCTs); the rising demand for personalized medicine in oncology; and advancements in genetic engineering. Utilization of CRISPR in biomedical research and the increasing demand for disease-specific models are also expected to contribute to market growth during the forecast period.

By model type, the inbred mice segment accounted for the largest share of the market in 2024.

The market is segmented by model type into inbred mice, genetically engineered mice, hybrid/congenic mice, and outbred mice. In 2024, the inbred mice segment accounted for the largest share of the mice model market. The large share of the inbred mice segment is attributed to the ability of inbred strains to provide genetic uniformity for preclinical studies, standardized breeding protocols that enable scalable production, and supply chains that support continuous availability. Regulatory frameworks at national and international levels recognize inbred strains as reference models for efficacy and safety assessment, and centralized breeding facilities implement quality control measures to maintain strain integrity. Adoption of inbred mice spans pharmaceutical and biotechnology companies and academic and government research institutions, where controlled genetic backgrounds reduce experimental variability.

By application, the drug discovery & development segment accounted for the largest share of the market in 2024.

The mice model market is segmented into drug discovery & development, research applications, and personalized medicine. In 2024, the drug discovery & development segment accounted for the largest share of the market. Mouse models are deployed in target validation assays to confirm the relevance of molecular targets, in lead optimization studies to compare pharmacodynamic profiles, and in efficacy evaluations to measure treatment responses under controlled conditions. Safety pharmacology protocols—cardiovascular, respiratory, and central nervous system endpoints—rely on telemetry recordings and behavioral assays conducted in mice. At the same time, reproductive and developmental toxicity assessments use timed-pregnancy protocols to determine embryonic viability and teratogenic risk. Histopathological examinations and clinical chemistry analyses of tissue samples support regulatory submissions, and omics profiling (transcriptomics, proteomics, metabolomics) informs dose selection and mechanism-of-action studies. Service providers integrate these applications into end-to-end workflows for end users. Combined, these integrated applications ensure the dominance of drug discovery & development applications in the mice model market.

By region, North America accounted for the largest share of the mice model market in 2024.

In 2024, North America accounted for the largest share of the mice model market due to the concentration of major contract research organizations and breeding suppliers, government and private funding mechanisms, and a regulatory environment emphasizing standardized preclinical practices. The key market players, such as Charles River Laboratories (US), The Jackson Laboratory (US), and Inotiv (US), have their presence in the region, thus ensuring regional supply and technical support. Public funding agencies such as the National Institutes of Health (NIH) allocate substantial budgets to basic & translational research, while pharmaceutical & biotechnology companies commit a significant portion of R&D expenditure to preclinical in vivo models. Academic research institutions and specialized contract research organizations leverage this infrastructure and funding landscape to conduct target validation, toxicology, and efficacy studies, reinforcing North America’s large share in the global mice model market.

The primary interviews conducted for this report can be categorized as follows:
  • By Respondent: Tier 1-25%, Tier 2-35%, and Tier 3- 40%
  • By Designation: C-level Executives - 55%, Directors- 20%, and Others- 25%
  • By Region: North America -45%, Europe - 20%, the Asia Pacific -20%, Latin America -10%, the Middle East- 3%, and Africa-2%
Charles River Laboratories (US), Inotiv (US), THE JACKSON LABORATORY (US), JSR Corporation (Japan), Biocytogen (China), TRANS GENIC INC. (Japan) Harbour BioMed (China), genOway (France), GemPharmatech (China), Cyagen (US), Ozgene Pty Ltd (Australia), Taconic Biosciences, Inc. (US), TransCure bioServices (France), Vivo Bio Tech Ltd (India), ingenious targeting laboratory (US), Janvier Labs (France), Champions Oncology, Inc (US), and Vitalstar Biotechnology Co., Ltd. (China) are some of the key companies offering mice model products & services.

Research Coverage:

This research report categorizes the mice model market by model type & service [model types (inbred mice, genetically engineered mice, hybrid/congenic mice, and outbred mice, breeding services, cryopreservation services, rederivation services, quarantine services, and other services)], by application (drug discovery & development, research applications, and personalized medicine), by technology (CRISPR/Cas9, microinjection, embryonic stem cell injection, nuclear transfer, and other technologies), by therapeutic area (oncology, neurology, immunology, metabolic diseases, cardiovascular diseases, and other therapeutic areas), by product end user (pharmaceutical & biotechnology companies, academic & research Institutes, and CROs & CDMOs), by services end user (pharmaceutical & biotechnology companies, government & biomedical research institutes, and CDMOs), and by region (North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa).

The report's scope covers detailed information regarding the primary factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the mice model market. A thorough analysis of the key industry players has been conducted to provide insights into their business overview, solutions, and services; key strategies; new product & service launches, acquisitions, and recent developments associated with the mice model market. This report covers the competitive analysis of upcoming startups in the mice model market ecosystem.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing the closest approximations of the revenue numbers for the mice model market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide information on the key market drivers, restraints, challenges, trends, and opportunities.

The report provides insights on the following :
  • Analysis of key drivers (high adoption of mice models in preclinical studies, the increasing demand for mouse clinical trials, the rising demand for personalized medicine in oncology, technological advancements in genetic engineering), restrains (the introduction of 3D printed models, ethical concerns, and regulatory restrictions), opportunities (Utilization of CRISPR in biomedical research, and the rising demand for disease-specific models), and challenges (development of alternative animal testing methods and genetic & phenotypic variability).
  • Product approvals: Detailed insights into newly approved products of the mice models market.
  • Market development: Comprehensive information about lucrative markets – the report analyses the mice model market across varied regions.
  • Market diversification: Exhaustive information about new products, recent developments, and investments in the mice model market.
  • Pipeline analysis: Comprehensive information about products under clinical trials.
  • Competitive assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players, including Charles River Laboratories (US), Inotiv (US), THE JACKSON LABORATORY (US), JSR Corporation (Japan), and Biocytogen (China).
Tables List
Table 1 Mice Model Market: Impact Analysis
Table 2 Mice Model Market: Risk Assessment Analysis
Table 3 Mice Model Market: Impact Analysis
Table 4 Average Selling Price Trend Of Model Types, By Key Player, 20222−2024
Table 5 Average Selling Price Of Model Types, By Region, 2024
Table 6 Mice Model Market: Role In Ecosystem, By Vendors
Table 7 Mice Model Market: Role In Ecosystem, By Service Vendor
Table 8 Mice Model Market: Role In Ecosystem, By End User
Table 9 Mice Model Market: Role In Ecosystem, By Regulatory Organization
Table 10 Patents Filed, By Document Type, 2014−2024
Table 11 Patents In Mice Models Market
Table 12 Import Value Of Hs Code 106.19.90–compliant Products For Top 20 Countries, 2020−2024 (Usd Thousands)
Table 13 Import Value Of Hs Code 106.19.90−compliant Products For Top 20 Countries, 2020−2024 (Usd Thousands)
Table 14 Mice Model Market: Conferences & Events (2025–2026)
Table 15 North America: List Of Regulatory Bodies, Government Agencies, And Other Organizations
Table 16 Europe: List Of Regulatory Bodies, Government Agencies, And Other Organizations
Table 17 Asia Pacific: List Of Regulatory Bodies, Government Agencies, And Other Organizations
Table 18 Rest Of The World: List Of Regulatory Bodies, Government Agencies, And Other Organizations
Table 19 Mice Model Market: Regulatory Scenario
Table 20 Mice Model Market: Porter’s Five Forces Analysis
Table 21 Investment & Funding Activities, By Key Player, 2022−2025
Table 22 Us-adjusted Reciprocal Tariff Rates
Table 23 Key Product-related Tariffs: Live Animals, Product Of Animal Origin, And Miscellaneous Chemical Products
Table 24 Critical Components Exposed To Tariff Changes
Table 25 Mice Model Market, By Model Type & Service, 2023–2030 (Usd Million)
Table 26 Mice Model Market, By Region, 2023–2030 (Usd Million)
Table 27 North America: Mice Model Type Market, By Country,
2023–2030 (Usd Million)
Table 28 Europe: Mice Model Type Market, By Country, 2023–2030 (Usd Million)
Table 29 Asia Pacific: Mice Model Type Market, By Country,
2023–2030 (Usd Million)
Table 30 Latin America: Mice Model Type Market, By Country,
2023–2030 (Usd Million)
Table 31 Middle East: Mice Model Type Market, By Region,
2023–2030 (Usd Million)
Table 32 Gcc Countries: Mice Model Type Market, By Country,
2023–2030 (Usd Million)
Table 33 Mice Model Market, By Type, 2023–2030 (Usd Million)
Table 34 Inbred Mice Model Market, By Region, 2023–2030 (Usd Million)
Table 35 North America: Inbred Mice Model Market, By Country,
2023–2030 (Usd Million)
Table 36 Europe: Inbred Mice Model Market, By Country,
2023–2030 (Usd Million)
Table 37 Asia Pacific: Inbred Mice Model Market, By Country,
2023–2030 (Usd Million)
Table 38 Latin America: Inbred Mice Model Market, By Country,
2023–2030 (Usd Million)
Table 39 Middle East: Inbred Mice Model Market, By Region,
2023–2030 (Usd Million)
Table 40 Gcc Countries: Inbred Mice Model Market, By Country,
2023–2030 (Usd Million)
Table 41 Genetically Engineered Mice Model Market, By Region,
2023–2030 (Usd Million)
Table 42 North America: Genetically Engineered Mice Model Market,
By Country, 2023–2030 (Usd Million)
Table 43 Europe: Genetically Engineered Mice Model Market, By Country,
2023–2030 (Usd Million)
Table 44 Asia Pacific: Genetically Engineered Mice Model Market, By Country, 2023–2030 (Usd Million)
Table 45 Latin America: Genetically Engineered Mice Model Market, By Country, 2023–2030 (Usd Million)
Table 46 Middle East: Genetically Engineered Mice Model Market, By Region, 2023–2030 (Usd Million)
Table 47 Gcc Countries: Genetically Engineered Mice Model Market, By Country, 2023–2030 (Usd Million)
Table 48 Hybrid/Congenic Mice Model Market, By Region,
2023–2030 (Usd Million)
Table 49 North America: Hybrid/Congenic Mice Model Market, By Country,
2023–2030 (Usd Million)
Table 50 Europe: Hybrid/Congenic Mice Model Market, By Country,
2023–2030 (Usd Million)
Table 51 Asia Pacific: Hybrid/Congenic Mice Model Market, By Country,
2023–2030 (Usd Million)
Table 52 Latin America: Hybrid/Congenic Mice Model Market, By Country,
2023–2030 (Usd Million)
Table 53 Middle East: Hybrid/Congenic Mice Model Market, By Region,
2023–2030 (Usd Million)
Table 54 Gcc Countries: Hybrid/Congenic Mice Model Market, By Country,
2023–2030 (Usd Million)
Table 55 Outbred Mice Model Market, By Region, 2023–2030 (Usd Million)
Table 56 North America: Outbred Mice Model Market, By Country,
2023–2030 (Usd Million)
Table 57 Europe: Outbred Mice Model Market, By Country,
2023–2030 (Usd Million)
Table 58 Asia Pacific: Outbred Mice Model Market, By Country,
2023–2030 (Usd Million)
Table 59 Latin America: Outbred Mice Model Market, By Country,
2023–2030 (Usd Million)
Table 60 Middle East: Outbred Mice Model Market, By Region,
2023–2030 (Usd Million)
Table 61 Gcc Countries: Outbred Mice Model Market, By Country,
2023–2030 (Usd Million)
Table 62 Mice Model Services Market, By Region, 2023–2030 (Usd Million)
Table 63 North America: Mice Model Services Market, By Country,
2023–2030 (Usd Million)
Table 64 Europe: Mice Model Services Market, By Country,
2023–2030 (Usd Million)
Table 65 Asia Pacific: Mice Model Services Market, By Country,
2023–2030 (Usd Million)
Table 66 Latin America: Mice Model Services Market, By Country,
2023–2030 (Usd Million)
Table 67 Middle East: Mice Model Services Market, By Region,
2023–2030 (Usd Million)
Table 68 Gcc Countries: Mice Model Services Market, By Country,
2023–2030 (Usd Million)
Table 69 Mice Model Services Market, By Type, 2023–2030 (Usd Million)
Table 70 Mice Model Breeding Services Market, By Region,
2023–2030 (Usd Million)
Table 71 North America: Mice Model Breeding Services Market, By Country, 2023–2030 (Usd Million)
Table 72 Europe: Mice Model Breeding Services Market, By Country,
2023–2030 (Usd Million)
Table 73 Asia Pacific: Mice Model Breeding Services Market, By Country,
2023–2030 (Usd Million)
Table 74 Latin America: Mice Model Breeding Services Market, By Country, 2023–2030 (Usd Million)
Table 75 Middle East: Mice Model Breeding Services Market, By Region,
2023–2030 (Usd Million)
Table 76 Gcc Countries: Mice Model Breeding Services Market, By Country, 2023–2030 (Usd Million)
Table 77 Mice Model Cryopreservation Services Market, By Region,
2023–2030 (Usd Million)
Table 78 North America: Mice Model Cryopreservation Services Market,
By Country, 2023–2030 (Usd Million)
Table 79 Europe: Mice Model Cryopreservation Services Market, By Country, 2023–2030 (Usd Million)
Table 80 Asia Pacific: Mice Model Cryopreservation Services Market,
By Country, 2023–2030 (Usd Million)
Table 81 Latin America: Mice Model Cryopreservation Services Market,
By Country, 2023–2030 (Usd Million)
Table 82 Middle East: Mice Model Cryopreservation Services Market, By Region 2023–2030 (Usd Million)
Table 83 Gcc Countries: Mice Model Cryopreservation Services Market,
By Country, 2023–2030 (Usd Million)
Table 84 Mice Model Rederivation Services Market, By Region,
2023–2030 (Usd Million)
Table 85 North America: Mice Model Rederivation Services Market, By Country, 2023–2030 (Usd Million)
Table 86 Europe: Mice Model Rederivation Services Market, By Country,
2023–2030 (Usd Million)
Table 87 Asia Pacific: Mice Model Rederivation Services Market, By Country, 2023–2030 (Usd Million)
Table 88 Latin America: Mice Model Rederivation Services Market, By Country, 2023–2030 (Usd Million)
Table 89 Middle East: Mice Model Rederivation Services, By Country,
2023–2030 (Usd Million)
Table 90 Gcc Countries: Mice Model Rederivation Services Market, By Country, 2023–2030 (Usd Million)
Table 91 Mice Model Quarantine Services Market, By Region,
2023–2030 (Usd Million)
Table 92 North America: Mice Model Quarantine Services Market, By Country, 2023–2030 (Usd Million)
Table 93 Europe: Mice Model Quarantine Services Market, By Country,
2023–2030 (Usd Million)
Table 94 Asia Pacific: Mice Model Quarantine Services Market, By Country,
2023–2030 (Usd Million)
Table 95 Latin America: Mice Model Quarantine Services Market, By Country, 2023–2030 (Usd Million)
Table 96 Middle East: Mice Model Quarantine Services Market, By Region,
2023–2030 (Usd Million)
Table 97 Gcc Countries: Mice Model Quarantine Services Market, By Country, 2023–2030 (Usd Million)
Table 98 Mice Model Market For Other Services, By Region,
2023–2030 (Usd Million)
Table 99 North America: Mice Model Market For Other Services, By Country, 2023–2030 (Usd Million)
Table 100 Europe: Mice Model Market For Other Services, By Country,
2023–2030 (Usd Million)
Table 101 Asia Pacific: Mice Model Market For Other Services, By Country,
2023–2030 (Usd Million)
Table 102 Latin America: Mice Model Market For Other Services, By Country, 2023–2030 (Usd Million)
Table 103 Middle East: Mice Model Market For Other Services, By Region,
2023–2030 (Usd Million)
Table 104 Gcc Countries: Mice Model Market For Other Services, By Country, 2023–2030 (Usd Million)
Table 105 Mice Model Market, By Technology, 2023–2030 (Usd Million)
Table 106 Mice Model Market For Crispr/Cas9, By Region,
2023–2030 (Usd Million)
Table 107 North America: Mice Model Market For Crispr/Cas9, By Country,
2023–2030 (Usd Million)
Table 108 Europe: Mice Model Market For Crispr/Cas9, By Country,
2023–2030 (Usd Million)
Table 109 Asia Pacific: Mice Model Market For Crispr/Cas9, By Country,
2023–2030 (Usd Million)
Table 110 Latin America: Mice Model Market For Crispr/Cas9, By Country,
2023–2030 (Usd Million)
Table 111 Middle East: Mice Model Market For Crispr/Cas9, By Region,
2023–2030 (Usd Million)
Table 112 Gcc Countries: Mice Model Market For Crispr/Cas9, By Country,
2023–2030 (Usd Million)
Table 113 Mice Model Market For Microinjections, By Region,
2023–2030 (Usd Million)
Table 114 North America: Mice Model Market For Microinjections, By Country, 2023–2030 (Usd Million)
Table 115 Europe: Mice Model Market For Microinjections, By Country,
2023–2030 (Usd Million)
Table 116 Asia Pacific: Mice Model Market For Microinjections, By Country,
2023–2030 (Usd Million)
Table 117 Latin America: Mice Model Market For Microinjections, By Country, 2023–2030 (Usd Million)
Table 118 Middle East: Mice Model Market For Microinjections, By Region,
2023–2030 (Usd Million)
Table 119 Gcc Countries: Mice Model Market For Microinjections, By Country, 2023–2030 (Usd Million)
Table 120 Mice Model Market For Embryonic Stem Cell Injections, By Region, 2023–2030 (Usd Million)
Table 121 North America: Mice Model Market For Embryonic Stem Cell Injections, By Country, 2023–2030 (Usd Million)
Table 122 Europe: Mice Model Market For Embryonic Stem Cell Injections,
By Country, 2023–2030 (Usd Million)
Table 123 Asia Pacific: Mice Model Market For Embryonic Stem Cell Injections,
By Country, 2023–2030 (Usd Million)
Table 124 Latin America: Mice Models Market For Embryonic Stem Cell Injections, By Country, 2023–2030 (Usd Million)
Table 125 Middle East: Mice Models Market For Embryonic Stem Cell Injections, By Region, 2023–2030 (Usd Million)
Table 126 Gcc Countries: Mice Models Market For Embryonic Stem Cell Injections, By Country, 2023–2030 (Usd Million)
Table 127 Mice Model Market For Nuclear Transfer Technique, By Region,
2023–2030 (Usd Million)
Table 128 North America: Mice Model Market For Nuclear Transfer Technique,
By Country, 2023–2030 (Usd Million)
Table 129 Europe: Mice Model Market For Nuclear Transfer Technique,
By Country, 2023–2030 (Usd Million)
Table 130 Asia Pacific: Mice Model Market For Nuclear Transfer Technique,
By Country, 2023–2030 (Usd Million)
Table 131 Latin America: Mice Model Market For Nuclear Transfer Technique,
By Country, 2023–2030 (Usd Million)
Table 132 Middle East: Mice Model Market For Nuclear Transfer Technique,
By Region, 2023–2030 (Usd Million)
Table 133 Gcc Countries: Mice Model Market For Nuclear Transfer Technique,
By Country, 2023–2030 (Usd Million)
Table 134 Mice Model Market For Other Technologies, By Region,
2023–2030 (Usd Million)
Table 135 North America: Mice Model Market For Other Technologies,
By Country, 2023–2030 (Usd Million)
Table 136 Europe: Mice Model Market For Other Technologies, By Country,
2023–2030 (Usd Million)
Table 137 Asia Pacific: Mice Model Market For Other Technologies, By Country, 2023–2030 (Usd Million)
Table 138 Latin America: Mice Model Market For Other Technologies, By Country, 2023–2030 (Usd Million)
Table 139 Middle East: Mice Model Market For Other Technologies, By Region, 2023–2030 (Usd Million)
Table 140 Gcc Countries: Mice Model Market For Other Technologies,
By Country, 2023–2030 (Usd Million)
Table 141 Mice Model Market, By Application, 2023–2030 (Usd Million)
Table 142 Mice Model Market For Drug Discovery & Development, By Region, 2023–2030 (Usd Million)
Table 143 North America: Mice Model Market For Drug Discovery & Development, By Country, 2023–2030 (Usd Million)
Table 144 Europe: Mice Model Market For Drug Discovery & Development,
By Country, 2023–2030 (Usd Million)
Table 145 Asia Pacific: Mice Model Market For Drug Discovery & Development,
By Country, 2023–2030 (Usd Million)
Table 146 Latin America: Mice Model Market For Drug Discovery & Development, By Country, 2023–2030 (Usd Million)
Table 147 Middle East: Mice Model Market For Drug Discovery & Development,
By Region, 2023–2030 (Usd Million)
Table 148 Gcc Countries: Mice Model Market For Drug Discovery & Development, By Country, 2023–2030 (Usd Million)
Table 149 Mice Model Market For Research Applications, By Region,
2023–2030 (Usd Million)
Table 150 North America: Mice Model Market For Research Applications,
By Country, 2023–2030 (Usd Million)
Table 151 Europe: Mice Model Market For Research Applications, By Country, 2023–2030 (Usd Million)
Table 152 Asia Pacific: Mice Model Market For Research Applications, By Country, 2023–2030 (Usd Million)
Table 153 Latin America: Mice Model Market For Research Applications,
By Country, 2023–2030 (Usd Million)
Table 154 Middle East: Mice Model Market For Research Applications, By Region, 2023–2030 (Usd Million)
Table 155 Gcc Countries: Mice Model Market For Research Applications,
By Country, 2023–2030 (Usd Million)
Table 156 Mice Model Market For Personalized Medicine, By Region,
2023–2030 (Usd Million)
Table 157 North America: Mice Model Market For Personalized Medicine,
By Country, 2023–2030 (Usd Million)
Table 158 Europe: Mice Model Market For Personalized Medicine, By Country, 2023–2030 (Usd Million)
Table 159 Asia Pacific: Mice Model Market For Personalized Medicine, By Country, 2023–2030 (Usd Million)
Table 160 Latin America: Mice Model Market For Personalized Medicine,
By Country, 2023–2030 (Usd Million)
Table 161 Middle East: Mice Model Market For Personalized Medicine, By Region, 2023–2030 (Usd Million)
Table 162 Gcc Countries: Mice Model Market For Personalized Medicine,
By Country, 2023–2030 (Usd Million)
Table 163 Mice Model Market, By Therapeutic Area, 2023–2030 (Usd Million)
Table 164 Mice Model Market For Oncology, By Region, 2023–2030 (Usd Million)
Table 165 North America: Mice Model Market For Oncology, By Country,
2023–2030 (Usd Million)
Table 166 Europe: Mice Model Market For Oncology, By Country,
2023–2030 (Usd Million)
Table 167 Asia Pacific: Mice Model Market For Oncology, By Country,
2023–2030 (Usd Million)
Table 168 Latin America: Mice Model Market For Oncology, By Country,
2023–2030 (Usd Million)
Table 169 Middle East: Mice Model Market For Oncology, By Region,
2023–2030 (Usd Million)
Table 170 Gcc Countries: Mice Model Market For Oncology, By Country,
2023–2030 (Usd Million)
Table 171 Mice Model Market For Metabolic Diseases, By Region,
2023–2030 (Usd Million)
Table 172 North America: Mice Model Market For Metabolic Diseases, By Country, 2023–2030 (Usd Million)
Table 173 Europe: Mice Model Market For Metabolic Diseases, By Country,
2023–2030 (Usd Million)
Table 174 Asia Pacific: Mice Model Market For Metabolic Diseases, By Country, 2023–2030 (Usd Million)
Table 175 Latin America: Mice Model Market For Metabolic Diseases, By Country, 2023–2030 (Usd Million)
Table 176 Middle East: Mice Model Market For Metabolic Diseases, By Region, 2023–2030 (Usd Million)
Table 177 Gcc Countries: Mice Model Market For Metabolic Diseases, By Country, 2023–2030 (Usd Million)
Table 178 Mice Model Market For Immunology, By Region,
2023–2030 (Usd Million)
Table 179 North America: Mice Model Market For Immunology, By Country,
2023–2030 (Usd Million)
Table 180 Europe: Mice Model Market For Immunology, By Country,
2023–2030 (Usd Million)
Table 181 Asia Pacific: Mice Model Market For Immunology, By Country,
2023–2030 (Usd Million)
Table 182 Latin America: Mice Model Market For Immunology, By Country,
2023–2030 (Usd Million)
Table 183 Middle East: Mice Model Market For Immunology, By Region,
2023–2030 (Usd Million)
Table 184 Gcc Countries: Mice Model Market For Immunology, By Country,
2023–2030 (Usd Million)
Table 185 Mice Model Market For Neurology, By Region, 2023–2030 (Usd Million)
Table 186 North America: Mice Model Market For Neurology, By Country,
2023–2030 (Usd Million)
Table 187 Europe: Mice Model Market For Neurology, By Country,
2023–2030 (Usd Million)
Table 188 Asia Pacific: Mice Model Market For Neurology, By Country,
2023–2030 (Usd Million)
Table 189 Latin America: Mice Model Market For Neurology, By Country,
2023–2030 (Usd Million)
Table 190 Middle East: Mice Model Market For Neurology, By Region,
2023–2030 (Usd Million)
Table 191 Gcc Countries: Mice Model Market For Neurology, By Country,
2023–2030 (Usd Million)
Table 192 Mice Model Market For Cardiovascular Diseases, By Region,
2023–2030 (Usd Million)
Table 193 North America: Mice Model Market For Cardiovascular Diseases,
By Country, 2023–2030 (Usd Million)
Table 194 Europe: Mice Model Market For Cardiovascular Diseases, By Country, 2023–2030 (Usd Million)
Table 195 Asia Pacific: Mice Model Market For Cardiovascular Diseases,
By Country, 2023–2030 (Usd Million)
Table 196 Latin America: Mice Model Market For Cardiovascular Diseases,
By Country, 2023–2030 (Usd Million)
Table 197 Middle East: Mice Model Market For Cardiovascular Diseases,
By Region, 2023–2030 (Usd Million)
Table 198 Gcc Countries: Mice Model Market For Cardiovascular Diseases,
By Country, 2023–2030 (Usd Million)
Table 199 Mice Model Market For Other Therapeutic Areas, By Region,
2023–2030 (Usd Million)
Table 200 North America: Mice Model Market For Other Therapeutic Areas,
By Country, 2023–2030 (Usd Million)
Table 201 Europe: Mice Model Market For Other Therapeutic Areas, By Country, 2023–2030 (Usd Million)
Table 202 Asia Pacific: Mice Model Market For Other Therapeutic Areas,
By Country, 2023–2030 (Usd Million)
Table 203 Latin America: Mice Model Market For Other Therapeutic Areas,
By Country, 2023–2030 (Usd Million)
Table 204 Middle East: Mice Model Market For Other Therapeutic Areas,
By Region, 2023–2030 (Usd Million)
Table 205 Gcc Countries: Mice Model Market For Other Therapeutic Areas,
By Country, 2023–2030 (Usd Million)
Table 206 Mice Model Type Market, By End User, 2023–2030 (Usd Million)
Table 207 Mice Model Type Market For Pharmaceutical & Biotechnology Companies, By Region, 2023–2030 (Usd Million)
Table 208 North America: Mice Model Type Market For Pharmaceutical & Biotechnology Companies, By Country, 2023–2030 (Usd Million)
Table 209 Europe: Mice Model Type Market For Pharmaceutical & Biotechnology Companies, By Country, 2023–2030 (Usd Million)
Table 210 Asia Pacific: Mice Model Type Market For Pharmaceutical & Biotechnology Companies, By Country, 2023–2030 (Usd Million)
Table 211 Latin America: Mice Model Type Market For Pharmaceutical & Biotechnology Companies, By Country, 2023–2030 (Usd Million)
Table 212 Middle East: Mice Model Type Market For Pharmaceutical & Biotechnology Companies, By Region, 2023–2030 (Usd Million)
Table 213 Gcc Countries: Mice Model Type Market For Pharmaceutical & Biotechnology Companies, By Country, 2023–2030 (Usd Million)
Table 214 Mice Model Type Market For Cros & Cdmos, By Region,
2023–2030 (Usd Million)
Table 215 North America: Mice Model Type Market For Cros & Cdmos, By Country, 2023–2030 (Usd Million)
Table 216 Europe: Mice Model Type Market For Cros & Cdmos, By Country,
2023–2030 (Usd Million)
Table 217 Asia Pacific: Mice Model Type Market For Cros & Cdmos, By Country, 2023–2030 (Usd Million)
Table 218 Latin America: Mice Model Type Market For Cros & Cdmos, By Country, 2023–2030 Usd Million)
Table 219 Middle East: Mice Model Type Market For Cros & Cdmos, By Region, 2023–2030 (Usd Million)
Table 220 Gcc Countries: Mice Model Type Market For Cros & Cdmos, By Country, 2023–2030 (Usd Million)
Table 221 Mice Model Type Market For Academic & Research Institutes, By Region, 2023–2030 (Usd Million)
Table 222 North America: Mice Model Type Market For Academic & Research Institutes, By Country, 2023–2030 (Usd Million)
Table 223 Europe: Mice Model Type Market For Academic & Research Institutes, By Country, 2023–2030 (Usd Million)
Table 224 Asia Pacific: Mice Model Type Market For Academic & Research Institutes, By Country, 2023–2030 (Usd Million)
Table 225 Latin America: Mice Model Type Market For Academic & Research Institutes, By Country, 2023–2030 (Usd Million)
Table 226 Middle East: Mice Model Type Market For Academic & Research Institutes, By Region, 2023–2030 (Usd Million)
Table 227 Gcc Countries: Mice Model Type Market For Academic & Research Institutes, By Country, 2023–2030 (Usd Million)
Table 228 Mice Model Services Market, By End User, 2023–2030 (Usd Million)
Table 229 Mice Model Services Market For Pharmaceutical & Biotechnology Companies, By Region, 2023–2030 (Usd Million)
Table 230 North America: Mice Model Services Market For Pharmaceutical & Biotechnology Companies, By Country, 2023–2030 (Usd Million)
Table 231 Europe: Mice Model Services Market For Pharmaceutical & Biotechnology Companies, By Country, 2023–2030 (Usd Million)
Table 232 Asia Pacific: Mice Model Services Market For Pharmaceutical & Biotechnology Companies, By Country, 2023–2030 (Usd Million)
Table 233 Latin America: Mice Model Services Market For Pharmaceutical & Biotechnology Companies, By Country, 2023–2030 (Usd Million)
Table 234 Middle East: Mice Model Services Market For Pharmaceutical & Biotechnology Companies, By Region, 2023–2030 (Usd Million)
Table 235 Gcc Countries: Mice Model Services Market For Pharmaceutical & Biotechnology Companies, By Country, 2023–2030 (Usd Million)
Table 236 Mice Model Services Market For Cdmos, By Region,
2023–2030 (Usd Million)
Table 237 North America: Mice Model Services Market For Cdmos, By Country, 2023–2030 (Usd Million)
Table 238 Europe: Mice Model Services Market For Cdmos, By Country,
2023–2030 (Usd Million)
Table 239 Asia Pacific: Mice Model Services Market For Cdmos, By Country,
2023–2030 (Usd Million)
Table 240 Latin America: Mice Model Services Market For Cdmos, By Country, 2023–2030 Usd Million)
Table 241 Middle East: Mice Model Services Market For Cdmos, By Region,
2023–2030 (Usd Million)
Table 242 Gcc Countries: Mice Model Services Market For Cdmos, By Country, 2023–2030 (Usd Million)
Table 243 Mice Model Services Market For Government & Biomedical Research Institutes, By Region, 2023–2030 (Usd Million)
Table 244 North America: Mice Model Services Market For Government & Biomedical Research Institutes, By Country, 2023–2030 (Usd Million)
Table 245 Europe: Mice Model Services Market For Government & Biomedical Research Institutes, By Country, 2023–2030 (Usd Million)
Table 246 Asia Pacific: Mice Model Services Market For Government & Biomedical Research Institutes, By Country, 2023–2030 (Usd Million)
Table 247 Latin America: Mice Model Services Market For Government & Biomedical Research Institutes, By Country, 2023–2030 (Usd Million)
Table 248 Middle East: Mice Model Services Market For Government & Biomedical Research Institutes, By Region, 2023–2030 (Usd Million)
Table 249 Gcc Countries: Mice Model Services Market For Government & Biomedical Research Institutes, By Country, 2023–2030 (Usd Million)
Table 250 Mice Model Market, By Region, 2023–2030 (Usd Million)
Table 251 North America: Macroeconomic Indicators
Table 252 North America: Mice Model Market, By Country,
2023–2030 (Usd Million)
Table 253 North America: Mice Model Market, By Model Type & Service,
2023–2030 (Usd Million)
Table 254 North America: Mice Model Market, By Type, 2023–2030 (Usd Million)
Table 255 North America: Mice Model Market, By Service, 2023–2030 (Usd Million)
Table 256 North America: Mice Model Market, By Technology,
2023–2030 (Usd Million)
Table 257 North America: Mice Model Market, By Therapeutic Area,
2023–2030 (Usd Million)
Table 258 North America: Mice Model Market, By Application,
2023–2030 (Usd Million)
Table 259 North America: Mice Model Type Market, By End User,
2023–2030 (Usd Million)
Table 260 North America: Mice Model Services Market, By End User,
2023–2030 (Usd Million
Table 261 Us: Mice Model Market, By Model Type & Service,
2023–2030 (Usd Million)
Table 262 Us: Mice Model Market, By Type, 2023–2030 (Usd Million)
Table 263 Us: Mice Model Market, By Service, 2023–2030 (Usd Million)
Table 264 Us: Mice Model Market, By Technology, 2023–2030 (Usd Million)
Table 265 Us: Mice Model Market, By Therapeutic Area, 2023–2030 (Usd Million)
Table 266 Us: Mice Model Market, By Application, 2023–2030 (Usd Million)
Table 267 Us: Mice Model Type Market, By End User, 2023–2030 (Usd Million)
Table 268 Us: Mice Model Services Market, By End User, 2023–2030 (Usd Million
Table 269 Canada: Mice Model Market, By Model Type & Service,
2023–2030 (Usd Million)
Table 270 Canada: Mice Model Market, By Type, 2023–2030 (Usd Million)
Table 271 Canada: Mice Model Market, By Service, 2023–2030 (Usd Million)
Table 272 Canada: Mice Model Market, By Technology, 2023–2030 (Usd Million)
Table 273 Canada: Mice Model Market, By Therapeutic Area,
2023–2030 (Usd Million)
Table 274 Canada: Mice Model Market, By Application, 2023–2030 (Usd Million)
Table 275 Canada: Mice Model Type Market, By End User, 2023–2030 (Usd Million)
Table 276 Canada: Mice Model Services Market, By End User,
2023–2030 (Usd Million
Table 277 Europe: Macroeconomic Indicators
Table 278 Europe: Mice Model Market, By Country, 2023–2030 (Usd Million)
Table 279 Europe: Mice Model Market, By Model Type & Service,
2023–2030 (Usd Million)
Table 280 Europe: Mice Model Market, By Type, 2023–2030 (Usd Million)
Table 281 Europe: Mice Model Market, By Service, 2023–2030 (Usd Million)
Table 282 Europe: Mice Model Market, By Technology, 2023–2030 (Usd Million)
Table 283 Europe: Mice Model Market, By Therapeutic Area,
2023–2030 (Usd Million)
Table 284 Europe: Mice Model Market, By Application, 2023–2030 (Usd Million)
Table 285 Europe: Mice Model Type Market, By End User, 2023–2030 (Usd Million)
Table 286 Europe: Mice Model Services Market, By End User,
2023–2030 (Usd Million
Table 287 Germany: Mice Model Market, By Model Type & Service,
2023–2030 (Usd Million)
Table 288 Germany: Mice Model Market, By Type, 2023–2030 (Usd Million)
Table 289 Germany: Mice Model Market, By Service, 2023–2030 (Usd Million)
Table 290 Germany: Mice Model Market, By Technology, 2023–2030 (Usd Million)
Table 291 Germany: Mice Model Market, By Therapeutic Area,
2023–2030 (Usd Million)
Table 292 Germany: Mice Model Market, By Application, 2023–2030 (Usd Million)
Table 293 Germany: Mice Model Type Market, By End User,
2023–2030 (Usd Million)
Table 294 Germany: Mice Model Services Market, By End User,
2023–2030 (Usd Million
Table 295 Uk: Mice Model Market, By Model Type & Service,
2023–2030 (Usd Million)
Table 296 Uk: Mice Model Market, By Type, 2023–2030 (Usd Million)
Table 297 Uk: Mice Model Market, By Service, 2023–2030 (Usd Million)
Table 298 Uk: Mice Model Market, By Technology, 2023–2030 (Usd Million)
Table 299 Uk: Mice Model Market, By Therapeutic Area, 2023–2030 (Usd Million)
Table 300 Uk: Mice Model Market, By Application, 2023–2030 (Usd Million)
Table 301 Uk: Mice Model Type Market, By End User, 2023–2030 (Usd Million)
Table 302 Uk: Mice Model Services Market, By End User, 2023–2030 (Usd Million
Table 303 France: Mice Model Market, By Model Type & Service,
2023–2030 (Usd Million)
Table 304 France: Mice Model Market, By Type, 2023–2030 (Usd Million)
Table 305 France: Mice Model Market, By Service, 2023–2030 (Usd Million)
Table 306 France: Mice Model Market, By Technology, 2023–2030 (Usd Million)
Table 307 France: Mice Model Market, By Therapeutic Area,
2023–2030 (Usd Million)
Table 308 France: Mice Model Market, By Application, 2023–2030 (Usd Million)
Table 309 France: Mice Model Type Market, By End User, 2023–2030 (Usd Million)
Table 310 France: Mice Model Services Market, By End User,
2023–2030 (Usd Million
Table 311 Italy: Mice Model Market, By Model Type & Service,
2023–2030 (Usd Million)
Table 312 Italy: Mice Model Market, By Type, 2023–2030 (Usd Million)
Table 313 Italy: Mice Model Market, By Service, 2023–2030 (Usd Million)
Table 314 Italy: Mice Model Market, By Technology, 2023–2030 (Usd Million)
Table 315 Italy: Mice Model Market, By Therapeutic Area, 2023–2030 (Usd Million)
Table 316 Italy: Mice Model Market, By Application, 2023–2030 (Usd Million)
Table 317 Italy: Mice Model Type Market, By End User, 2023–2030 (Usd Million)
Table 318 Italy: Mice Model Services Market, By End User, 2023–2030 (Usd Million
Table 319 Spain: Mice Model Market, By Model Type & Service,
2023–2030 (Usd Million)
Table 320 Spain: Mice Model Market, By Type, 2023–2030 (Usd Million)
Table 321 Spain: Mice Model Market, By Service, 2023–2030 (Usd Million)
Table 322 Spain: Mice Model Market, By Technology, 2023–2030 (Usd Million)
Table 323 Spain: Mice Model Market, By Therapeutic Area, 2023–2030 (Usd Million)
Table 324 Spain: Mice Model Market, By Application, 2023–2030 (Usd Million)
Table 325 Spain: Mice Model Type Market, By End User, 2023–2030 (Usd Million)
Table 326 Spain: Mice Model Services Market, By End User,
2023–2030 (Usd Million
Table 327 Rest Of Europe: Mice Model Market, By Model Type & Service,
2023–2030 (Usd Million)
Table 328 Rest Of Europe: Mice Model Market, By Type, 2023–2030 (Usd Million)
Table 329 Rest Of Europe: Mice Model Market, By Service,
2023–2030 (Usd Million)
Table 330 Rest Of Europe: Mice Model Market, By Technology,
2023–2030 (Usd Million)
Table 331 Rest Of Europe: Mice Model Market, By Therapeutic Area,
2023–2030 (Usd Million)
Table 332 Rest Of Europe: Mice Model Market, By Application,
2023–2030 (Usd Million)
Table 333 Rest Of Europe: Mice Model Type Market, By End User,
2023–2030 (Usd Million)
Table 334 Rest Of Europe: Mice Model Services Market, By End User,
2023–2030 (Usd Million
Table 335 Asia Pacific: Macroeconomic Indicators
Table 336 Asia Pacific: Mice Model Market, By Country, 2023–2030 (Usd Million)
Table 337 Asia Pacific: Mice Model Market, By Model Type & Service,
2023–2030 (Usd Million)
Table 338 Asia Pacific: Mice Model Market, By Type, 2023–2030 (Usd Million)
Table 339 Asia Pacific: Mice Model Market, By Service, 2023–2030 (Usd Million)
Table 340 Asia Pacific: Mice Model Market, By Technology,
2023–2030 (Usd Million)
Table 341 Asia Pacific: Mice Model Market, By Therapeutic Area,
2023–2030 (Usd Million)
Table 342 Asia Pacific: Mice Model Market, By Application, 2023–2030 (Usd Million)
Table 343 Asia Pacific: Mice Model Type Market, By End User,
2023–2030 (Usd Million)
Table 344 Asia Pacific: Mice Model Services Market, By End User,
2023–2030 (Usd Million
Table 345 China: Mice Model Market, By Model Type & Service,
2023–2030 (Usd Million)
Table 346 China: Mice Model Market, By Type, 2023–2030 (Usd Million)
Table 347 China: Mice Model Market, By Service, 2023–2030 (Usd Million)
Table 348 China: Mice Model Market, By Technology, 2023–2030 (Usd Million)
Table 349 China: Mice Model Market, By Therapeutic Area,
2023–2030 (Usd Million)
Table 350 China: Mice Model Market, By Application, 2023–2030 (Usd Million)
Table 351 China: Mice Model Type Market, By End User, 2023–2030 (Usd Million)
Table 352 China: Mice Model Services Market, By End User,
2023–2030 (Usd Million
Table 353 Japan: Mice Model Market, By Model Type & Service,
2023–2030 (Usd Million)
Table 354 Japan: Mice Model Market, By Type, 2023–2030 (Usd Million)
Table 355 Japan: Mice Model Market, By Service, 2023–2030 (Usd Million)
Table 356 Japan: Mice Model Market, By Technology, 2023–2030 (Usd Million)
Table 357 Japan: Mice Model Market, By Therapeutic Area,
2023–2030 (Usd Million)
Table 358 Japan: Mice Model Market, By Application, 2023–2030 (Usd Million)
Table 359 Japan: Mice Model Type Market, By End User, 2023–2030 (Usd Million)
Table 360 Japan: Mice Model Services Market, By End User,
2023–2030 (Usd Million
Table 361 India: Mice Model Market, By Model Type & Service,
2023–2030 (Usd Million)
Table 362 India: Mice Model Market, By Type, 2023–2030 (Usd Million)
Table 363 India: Mice Model Market, By Service, 2023–2030 (Usd Million)
Table 364 India: Mice Model Market, By Technology, 2023–2030 (Usd Million)
Table 365 India: Mice Model Market, By Therapeutic Area, 2023–2030 (Usd Million)
Table 366 India: Mice Model Market, By Application, 2023–2030 (Usd Million)
Table 367 India: Mice Model Type Market, By End User, 2023–2030 (Usd Million)
Table 368 India: Mice Model Services Market, By End User, 2023–2030 (Usd Million
Table 369 Australia: Mice Model Market, By Model Type & Service,
2023–2030 (Usd Million)
Table 370 Australia: Mice Model Market, By Type, 2023–2030 (Usd Million)
Table 371 Australia: Mice Model Market, By Service, 2023–2030 (Usd Million)
Table 372 Australia: Mice Model Market, By Technology, 2023–2030 (Usd Million)
Table 373 Australia: Mice Model Market, By Therapeutic Area,
2023–2030 (Usd Million)
Table 374 Australia: Mice Model Market, By Application, 2023–2030 (Usd Million)
Table 375 Australia: Mice Model Type Market, By End User,
2023–2030 (Usd Million)
Table 376 Australia: Mice Model Services Market, By End User,
2023–2030 (Usd Million
Table 377 South Korea: Mice Model Market, By Model Type & Service,
2023–2030 (Usd Million)
Table 378 South Korea: Mice Model Market, By Type, 2023–2030 (Usd Million)
Table 379 South Korea: Mice Model Market, By Service, 2023–2030 (Usd Million)
Table 380 South Korea: Mice Model Market, By Technology,
2023–2030 (Usd Million)
Table 381 South Korea: Mice Model Market, By Therapeutic Area,
2023–2030 (Usd Million)
Table 382 South Korea: Mice Model Market, By Application,
2023–2030 (Usd Million)
Table 383 South Korea: Mice Model Type Market, By End User,
2023–2030 (Usd Million)
Table 384 South Korea: Mice Model Services Market, By End User,
2023–2030 (Usd Million
Table 385 Rest Of Asia Pacific: Mice Model Market, By Model Type & Service,
2023–2030 (Usd Million)
Table 386 Rest Of Asia Pacific: Mice Model Market, By Type,
2023–2030 (Usd Million)
Table 387 Rest Of Asia Pacific: Mice Model Market, By Service,
2023–2030 (Usd Million)
Table 388 Rest Of Asia Pacific: Mice Model Market, By Technology,
2023–2030 (Usd Million)
Table 389 Rest Of Asia Pacific: Mice Model Market, By Therapeutic Area,
2023–2030 (Usd Million)
Table 390 Rest Of Asia Pacific: Mice Model Market, By Application,
2023–2030 (Usd Million)
Table 391 Rest Of Asia Pacific: Mice Model Type Market, By End User,
2023–2030 (Usd Million)
Table 392 Rest Of Asia Pacific: Mice Model Services Market, By End User,
2023–2030 (Usd Million
Table 393 Latin America: Macroeconomic Indicators
Table 394 Latin America: Mice Model Market, By Country, 2023–2030 (Usd Million)
Table 395 Latin America: Mice Model Market, By Model Type & Service,
2023–2030 (Usd Million)
Table 396 Latin America: Mice Model Market, By Type, 2023–2030 (Usd Million)
Table 397 Latin America: Mice Model Market, By Service, 2023–2030 (Usd Million)
Table 398 Latin America: Mice Model Market, By Technology,
2023–2030 (Usd Million)
Table 399 Latin America: Mice Model Market, By Therapeutic Area,
2023–2030 (Usd Million)
Table 400 Latin America: Mice Model Market, By Application,
2023–2030 (Usd Million)
Table 401 Latin America: Mice Model Type Market, By End User,
2023–2030 (Usd Million)
Table 402 Latin America: Mice Model Services Market, By End User,
2023–2030 (Usd Million
Table 403 Brazil: Mice Model Market, By Model Type & Service,
2023–2030 (Usd Million)
Table 404 Brazil: Mice Model Market, By Type, 2023–2030 (Usd Million)
Table 405 Brazil: Mice Model Market, By Service, 2023–2030 (Usd Million)
Table 406 Brazil: Mice Model Market, By Technology, 2023–2030 (Usd Million)
Table 407 Brazil: Mice Model Market, By Therapeutic Area,
2023–2030 (Usd Million)
Table 408 Brazil: Mice Model Market, By Application, 2023–2030 (Usd Million)
Table 409 Brazil: Mice Model Type Market, By End User, 2023–2030 (Usd Million)
Table 410 Brazil: Mice Model Services Market, By End User,
2023–2030 (Usd Million
Table 411 Mexico: Mice Model Market, By Model Type & Service,
2023–2030 (Usd Million)
Table 412 Mexico: Mice Model Market, By Type, 2023–2030 (Usd Million)
Table 413 Mexico: Mice Model Market, By Service, 2023–2030 (Usd Million)
Table 414 Mexico: Mice Model Market, By Technology, 2023–2030 (Usd Million)
Table 415 Mexico: Mice Model Market, By Therapeutic Area,
2023–2030 (Usd Million)
Table 416 Mexico: Mice Model Market, By Application, 2023–2030 (Usd Million)
Table 417 Mexico: Mice Model Type Market, By End User, 2023–2030 (Usd Million)
Table 418 Mexico: Mice Model Services Market, By End User,
2023–2030 (Usd Million
Table 419 Rest Of Latin America: Mice Model Market, By Model Type & Service, 2023–2030 (Usd Million)
Table 420 Rest Of Latin America: Mice Model Market, By Type,
2023–2030 (Usd Million)
Table 421 Rest Of Latin America: Mice Model Market, By Service,
2023–2030 (Usd Million)
Table 422 Rest Of Latin America: Mice Model Market, By Technology,
2023–2030 (Usd Million)
Table 423 Rest Of Latin America: Mice Model Market, By Therapeutic Area,
2023–2030 (Usd Million)
Table 424 Rest Of Latin America: Mice Model Market, By Application,
2023–2030 (Usd Million)
Table 425 Rest Of Latin America: Mice Model Type Market, By End User,
2023–2030 (Usd Million)
Table 426 Rest Of Latin America: Mice Model Services Market, By End User,
2023–2030 (Usd Million)
Table 427 Middle East: Macroeconomic Indicators
Table 428 Middle East: Mice Model Market, By Region, 2023–2030 (Usd Million)
Table 429 Middle East: Mice Model Market, By Model Type & Service,
2023–2030 (Usd Million)
Table 430 Middle East: Mice Model Market, By Type, 2023–2030 (Usd Million)
Table 431 Middle East: Mice Model Market, By Service, 2023–2030 (Usd Million)
Table 432 Middle East: Mice Model Market, By Technology,
2023–2030 (Usd Million)
Table 433 Middle East: Mice Model Market, By Therapeutic Area,
2023–2030 (Usd Million)
Table 434 Middle East: Mice Model Market, By Application,
2023–2030 (Usd Million)
Table 435 Middle East: Mice Model Type Market, By End User,
2023–2030 (Usd Million)
Table 436 Middle East: Mice Model Services Market, By End User,
2023–2030 (Usd Million)
Table 437 Gcc Countries: Mice Model Market, By Country,
2023–2030 (Usd Million)
Table 438 Gcc Countries: Mice Model Market, By Model Type & Service,
2023–2030 (Usd Million)
Table 439 Gcc Countries: Mice Model Market, By Type, 2023–2030 (Usd Million)
Table 440 Gcc Countries: Mice Model Market, By Service, 2023–2030 (Usd Million)
Table 441 Gcc Countries: Mice Model Market, By Technology,
2023–2030 (Usd Million)
Table 442 Gcc Countries: Mice Model Market, By Therapeutic Area,
2023–2030 (Usd Million)
Table 443 Gcc Countries: Mice Model Market, By Application,
2023–2030 (Usd Million)
Table 444 Gcc Countries: Mice Model Type Market, By End User,
2023–2030 (Usd Million)
Table 445 Gcc Countries: Mice Model Services Market, By End User,
2023–2030 (Usd Million)
Table 446 Kingdom Of Saudi Arabia: Mice Model Market, By Model Type & Service, 2023–2030 (Usd Million)
Table 447 Kingdom Of Saudi Arabia: Mice Model Market, By Type,
2023–2030 (Usd Million)
Table 448 Kingdom Of Saudi Arabia: Mice Model Market, By Service,
2023–2030 (Usd Million)
Table 449 Kingdom Of Saudi Arabia: Mice Model Market, By Technology,
2023–2030 (Usd Million)
Table 450 Kingdom Of Saudi Arabia: Mice Model Market, By Therapeutic Area, 2023–2030 (Usd Million)
Table 451 Kingdom Of Saudi Arabia: Mice Model Market, By Application,
2023–2030 (Usd Million)
Table 452 Kingdom Of Saudi Arabia: Mice Model Type Market, By End User,
2023–2030 (Usd Million)
Table 453 Kingdom Of Saudi Arabia: Mice Model Services Market, By End User, 2023–2030 (Usd Million)
Table 454 United Arab Emirates: Mice Model Market, By Model Type & Service, 2023–2030 (Usd Million)
Table 455 United Arab Emirates: Mice Model Market, By Type,
2023–2030 (Usd Million)
Table 456 United Arab Emirates: Mice Model Market, By Service,
2023–2030 (Usd Million)
Table 457 United Arab Emirates: Mice Model Market, By Technology,
2023–2030 (Usd Million)
Table 458 United Arab Emirates: Mice Model Market, By Therapeutic Area,
2023–2030 (Usd Million)
Table 459 United Arab Emirates: Mice Model Market, By Application,
2023–2030 (Usd Million)
Table 460 United Arab Emirates: Mice Model Type Market, By End User,
2023–2030 (Usd Million)
Table 461 United Arab Emirates: Mice Model Services Market, By End User,
2023–2030 (Usd Million)
Table 462 Other Gcc Countries: Mice Model Market, By Model Type & Service, 2023–2030 (Usd Million)
Table 463 Other Gcc Countries: Mice Model Market, By Type,
2023–2030 (Usd Million)
Table 464 Other Gcc Countries: Mice Model Market, By Service,
2023–2030 (Usd Million)
Table 465 Other Gcc Countries: Mice Model Market, By Technology,
2023–2030 (Usd Million)
Table 466 Other Gcc Countries: Mice Model Market, By Therapeutic Area,
2023–2030 (Usd Million)
Table 467 Other Gcc Countries: Mice Model Market, By Application,
2023–2030 (Usd Million)
Table 468 Other Gcc Countries: Mice Model Type Market, By End User,
2023–2030 (Usd Million)
Table 469 Other Gcc Countries: Mice Model Services Market, By End User,
2023–2030 (Usd Million)
Table 470 Rest Of Middle East: Mice Model Market, By Model Type & Service, 2023–2030 (Usd Million)
Table 471 Rest Of Middle East: Mice Model Market, By Type,
2023–2030 (Usd Million)
Table 472 Rest Of Middle East: Mice Model Market, By Service,
2023–2030 (Usd Million)
Table 473 Rest Of Middle East: Mice Model Market, By Technology,
2023–2030 (Usd Million)
Table 474 Rest Of Middle East: Mice Model Market, By Therapeutic Area,
2023–2030 (Usd Million)
Table 475 Rest Of Middle East: Mice Model Market, By Application,
2023–2030 (Usd Million)
Table 476 Rest Of Middle East: Mice Model Type Market, By End User,
2023–2030 (Usd Million)
Table 477 Rest Of Middle East: Mice Model Services Market, By End User,
2023–2030 (Usd Million)
Table 478 Macroeconomic Outlook For Africa
Table 479 Africa: Mice Model Market, By Model Type & Service,
2023–2030 (Usd Million)
Table 480 Africa: Mice Model Market, By Type, 2023–2030 (Usd Million)
Table 481 Africa: Mice Model Market, By Service, 2023–2030 (Usd Million)
Table 482 Africa: Mice Model Market, By Technology, 2023–2030 (Usd Million)
Table 483 Africa: Mice Model Market, By Therapeutic Area,
2023–2030 (Usd Million)
Table 484 Africa: Mice Model Market, By Application, 2023–2030 (Usd Million)
Table 485 Africa: Mice Model Type Market, By End User, 2023–2030 (Usd Million)
Table 486 Africa: Mice Model Services Market, By End User,
2023–2030 (Usd Million)
Table 487 Strategies Adopted By Key Players In Mice Model Market, 2022−2025
Table 488 Mice Model Market: Intensity Of Competitive Rivalry
Table 489 Mice Model Market: Region Footprint
Table 490 Mice Model Market: Model Type & Service Footprint
Table 491 Mice Model Market: Application Footprint
Table 492 Mice Model Market: Technology Footprint
Table 493 Mice Model Market: Therapeutic Area Footprint
Table 494 Mice Model Market: Detailed List Of Key Startups/Sme Players
Table 495 Mice Model Market: Competitive Benchmarking Of Key Startups/Smes
Table 496 Mice Model Market: Product/Service Launches,
January 2022−june 2025
Table 497 Mice Model Market: Deals, January 2022−june 2025
Table 498 Mice Model Market: Expansions, January 2022−june 2025
Table 499 Mice Model Market: Other Developments, January 2022−june 2025
Table 500 Charles River Laboratories: Company Overview
Table 501 Charles River Laboratories: Products/Services Offered
Table 502 Charles River Laboratories: Deals, January 2022−june 2025
Table 503 Charles River Laboratories: Expansions, January 2022−june 2025
Table 504 Charles River Laboratories: Other Developments,
January 2022−june 2025
Table 505 The Jackson Laboratory: Company Overview
Table 506 The Jackson Laboratory: Products/Services Offered
Table 507 The Jackson Laboratory: Deals, January 2022−june 2025
Table 508 The Jackson Laboratory: Expansions, January 2022−june 2025
Table 509 Inotiv: Company Overview
Table 510 Inotiv: Products/Services Offered
Table 511 Inotiv: Deals, January 2022−june 2025
Table 512 Inotiv: Expansions, January 2022−june 2025
Table 513 Jsr Corporation: Company Overview
Table 514 Jsr Corporation: Products/Services Offered
Table 515 Jsr Corporation: Deals, January 2022−june 2025
Table 516 Jsr Corporation: Expansions, January 2022−june 2025
Table 517 Biocytogen: Company Overview
Table 518 Biocytogen: Products/Services Offered
Table 519 Biocytogen: Product/Service Launches, January 2022−june 2025
Table 520 Biocytogen: Deals, January 2022−june 2025
Table 521 Biocytogen: Expansions, January 2022−june 2025
Table 522 Shanghai Model Organisms Center, Inc.: Company Overview
Table 523 Shanghai Model Organisms Center, Inc.: Products/Services Offered
Table 524 Shanghai Model Organisms Center, Inc.: Deals, January 2022−june 2025
Table 525 Trans Genic Inc.: Company Overview
Table 526 Trans Genic, Inc.: Products/Services Offered
Table 527 Trans Genic, Inc.: Deals, January 2022−june 2025
Table 528 Harbour Biomed: Company Overview
Table 529 Harbour Biomed: Products/Services Offered
Table 530 Harbour Biomed: Deals, January 2022−june 2025
Table 531 Harbour Biomed: Other Developments, January 2022−june 2025
Table 532 Genoway: Company Overview
Table 533 Genoway: Products/Services Offered
Table 534 Genoway: Deals, January 2022−june 2025
Table 535 Gempharmatech: Company Overview
Table 536 Gempharmatech: Products/Services Offered
Table 537 Gempharmatech: Product/Service Launches, January 2022−june 2025
Table 538 Gempharmatech: Deals, January 2022−june 2025
Table 539 Gempharmatech: Expansions, January 2022−june 2025
Table 540 Cyagen: Company Overview
Table 541 Cyagen: Products/Services Offered
Table 542 Cyagen: Deals, January 2022−june 2025
Table 543 Ozgene Pty Ltd.: Company Overview
Table 544 Ozgene Pty Ltd.: Products/Services Offered
Table 545 Ozgene Pty. Ltd: Deals, January 2022−june 2025
Table 546 Taconic Biosciences, Inc.: Company Overview
Table 547 Taconic Biosciences, Inc.: Products/Services Offered
Table 548 Taconic Biosciences, Inc.: Product/Service Launches,
January 2022−june 2025
Table 549 Taconic Biosciences, Inc.: Deals, January 2022−june 2025
Table 550 Taconic Biosciences, Inc.: Expansions, January 2022−june 2025
Table 551 Transcure Bioservices: Company Overview
Table 552 Transcure Bioservices: Products/Services Offered
Table 553 Transcure Bioservices: Deals, January 2022−june 2025
Table 554 Vivo Bio Tech Ltd.: Company Overview
Table 555 Vivo Bio Tech Ltd.: Products/Services Offered
Table 556 Ingenious Targeting Laboratory: Company Overview
Table 557 Ingenious Targeting Laboratory: Products/Services Offered
Table 558 Janvier Labs: Company Overview
Table 559 Janvier Labs: Products/Services Offered
Table 560 Janvier Labs: Deals, January 2022−june 2025
Table 561 Champions Oncology, Inc.: Company Overview
Table 562 Champions Oncology, Inc.: Products Offered
Table 563 Champions Oncology, Inc.: Deals, January 2022−june 2025
Table 564 Vitalstar Biotechnology Co., Ltd.: Company Overview
Table 565 Vitalstar Biotechnology Co., Ltd.: Products Offered
Table 566 Oncodesign Services: Company Overview
Table 567 Clea Japan, Inc.: Company Overview
Table 568 Applied Stemcell: Company Overview
Table 569 Creative Animodel: Company Overview
Table 570 Joinn Laboratories (China) Co., Ltd.: Company Overview
Table 571 Creative Biolabs: Company Overview
Table 572 Crescendo Biologics Limited: Company Overview
Table 573 Aragen Life Sciences Ltd.: Business Overview
Table 574 Polygene: Business Overview
Table 575 Pharmatest: Business Overview
Table 576 Marshall Bioresources: Business Overview
Figures List
Figure 1 Mice Model Market Segmentation
Figure 2 Research Design
Figure 3 Mice Model Market: Breakdown Of Primaries
Figure 4 Mice Model Market Size Estimation (Supply-side Analysis), 2024
Figure 5 Market Size Estimation: Approach 1 (Company Revenue
Analysis-based Estimation), 2024
Figure 6 Illustrative Example Of Charles River Laboratories:
Revenue Share Analysis (2024)
Figure 7 Market Size Validation From Primary Sources
Figure 8 Market Size Estimation Methodology: Top-down Approach
Figure 9 Mice Model Market: Cagr Projections
Figure 10 Data Triangulation Methodology
Figure 11 Mice Model Market, By Model Type & Service,
2025 Vs. 2030 (Usd Million)
Figure 12 Mice Model Market, By Technology, 2025 Vs. 2030 (Usd Million)
Figure 13 Mice Model Market, By Therapeutic Area, 2025 Vs. 2030 (Usd Million)
Figure 14 Mice Model Market, By Application, 2025 Vs. 2030 (Usd Million)
Figure 15 Geographic Snapshot Of Mice Model Market
Figure 16 Rising Demand For Mouse Clinical Trials To Propel Market
Figure 17 Model Type Segment Accounted For Largest Market Share In 2024
Figure 18 China To Register Highest Growth Rate During Forecast Period
Figure 19 Pharmaceutical & Biotechnology Companies To Dominate Market During Forecast Period
Figure 20 Pharmaceutical & Biotechnology Companies To Dominate Market During Forecast Period
Figure 21 Mice Model Market: Drivers, Restraints, Opportunities,
And Challenges
Figure 22 Mice Model Market: Value Chain Analysis
Figure 23 Average Selling Price Trend Of Model Types, By Key Player,
2022–2024 (Usd)
Figure 24 Average Selling Price Of Model Types, By Region (Usd)
Figure 25 Mice Model Market: Ecosystem Analysis
Figure 26 Trends/Disruptions Impacting Customers’ Businesses
Figure 27 Patent Applications In Mice Model Market,
January 2014−december 2024
Figure 28 Mice Model Market: Porter’s Five Forces Analysis
Figure 29 Influence Of Stakeholders On Buying Process For Mice Model Market
Figure 30 Key Buying Criteria For End Users
Figure 31 Investment & Funding Scenario, 2022–2025
Figure 32 Ai-use Cases In Mice Model Market
Figure 33 North America: Mice Model Market Snapshot
Figure 34 Asia Pacific: Mice Model Market Snapshot
Figure 35 Revenue Share Analysis For Key Companies, 2022–2024 (Usd Million)
Figure 36 Mice Model Market Share Analysis Of Key Players (2024)
Figure 37 Mice Model Market: Company Evaluation Matrix (Key Players) 2024,
Figure 38 Mice Model Market: Company Footprint
Figure 39 Mice Model Market: Company Evaluation Matrix (Startups/Smes), 2024
Figure 40 Ev/Ebitda Of Key Vendors
Figure 41 Year-to-date (Ytd) Price, Total Return, And 5-year Stock
Beta Of Key Vendors
Figure 42 Mice Model Market: Brand/Product Comparative Analysis
Figure 43 Charles River Laboratories: Company Snapshot (2024)
Figure 44 The Jackson Laboratory: Company Snapshot (2024)
Figure 45 Inotiv: Company Snapshot (2024)
Figure 46 Jsr Corporation: Company Snapshot (2023)
Figure 47 Biocytogen: Company Snapshot (2024)
Figure 48 Shanghai Model Organisms Center, Inc.: Company Snapshot (2024)
Figure 49 Trans Genic Inc.: Company Snapshot (2024)
Figure 50 Harbour Biomed: Company Snapshot (2024)
Figure 51 Genoway: Company Snapshot (2024)
Figure 52 Gempharmatech: Company Snapshot (2024)
Figure 53 Vivo Bio Tech Ltd.: Company Snapshot (2023)
Figure 54 Champions Oncology, Inc.: Company Snapshot (2023)

Table of Contents

446 Pages
1 Introduction
1.1 Study Objectives
1.2 Market Definition
1.3 Market Scope
1.3.1 Inclusions & Exclusions
1.3.2 Markets & Regions Covered
1.3.3 Years Considered
1.3.4 Currency Considered
1.4 Stakeholders
1.5 Summary Of Changes
2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.2 Primary Data
2.2 Market Estimation Methodology
2.2.1 Bottom-up Approach
2.2.2 Insights From Primary Experts
2.3 Top-down Approach
2.4 Growth Forecast
2.5 Market Breakdown And Data Triangulation
2.6 Research Assumptions
2.7 Limitations
2.8 Market Forecast
2.9 Risk Analysis
3 Executive Summary
4 Premium Insights
4.1 Mice Model Market Overview
4.2 North America: Mice Model Market, By Model Type & Service (2024)
4.3 Mice Model Market: Geographic Growth Opportunities
4.4 Mice Model Market, By Model Type (End User), 2025 Vs. 2030
4.5 Mice Model Market Share, By Services (End User)
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 High Adoption Of Mice Models In Preclinical Studies
5.2.1.2 Increasing Demand For Mouse Clinical Trials (Mcts)
5.2.1.3 Growing Preference For Personalized Medicine In Oncology
5.2.1.4 Advancements In Genetic Engineering
5.2.2 Restraints
5.2.2.1 Introduction Of 3d Printed Models
5.2.2.2 Ethical Concerns And Regulatory Restrictions
5.2.3 Opportunities
5.2.3.1 Utilization Of Crispr In Biomedical Research
5.2.3.2 Rising Demand For Disease-specific Models
5.2.4 Challenges
5.2.4.1 Development Of Alternative Animal Testing Methods
5.2.4.2 Genetic & Phenotypic Variability
5.3 Mice Model Market Landscape
5.3.1 History Of Mice Models
5.3.2 Mice Model Generation Process
5.3.3 Techniques For Mice Model Development
5.3.4 Technological Advancements
5.3.5 Considerations For Mice Model Development
5.4 Value Chain Analysis
5.5 Pricing Analysis
5.5.1 Average Selling Price Trend Of Products, By Key Player, 2022−2024
5.5.2 Average Selling Price Of Model Types, By Region, 2024
5.6 Ecosystem Analysis
5.6.1 Mice Model Vendors
5.6.2 Mice Model Service Vendors
5.6.3 Mice Model End Users
5.6.4 Regulatory Organizations
5.7 Technology Analysis
5.7.1 Key Technologies
5.7.1.1 Crispr/Cas9 Gene Editing
5.7.1.2 Pronuclear Microinjection (Pni)
5.7.1.3 Embryo Cryopreservation & Assisted Reproduction
5.7.2 Complementary Technologies
5.7.2.1 Multimodal Preclinical Imaging
5.7.2.2 Automated Behavioural Phenotyping
5.7.2.3 Integrated Physiological Monitoring
5.7.3 Adjacent Technologies
5.7.3.1 Ex Vivo Crispr Screening In Cell Culture
5.7.3.2 High-content Bioinformatics Pipeline
5.7.3.3 Mass Spectroscopy-based Tissue Profiling
5.8 Trends/Disruptions Impacting Customers’ Businesses
5.9 Patent Analysis
5.9.1 Methodology
5.9.2 Patents Filed, By Document Type, 2014−2024
5.10 Trade Data Analysis
5.10.1 Import Data
5.10.2 Import Data
5.11 Key Conferences & Events
5.11.1 Key Conferences & Events (2025–2026)
5.12 Tariff & Regulatory Landscape
5.12.1 Tariff Data (Hs Code 106.19.90)
5.12.2 Regulatory Bodies, Government Agencies, And Other Organizations
5.12.3 Regulatory Framework
5.12.3.1 North America
5.12.3.2 Europe
5.12.3.3 China
5.12.3.4 Japan
5.12.3.5 India
5.12.3.6 Australia
5.12.3.7 Brazil
5.13 Porter’s Five Forces Analysis
5.13.1 Threat Of New Entrants
5.13.2 Threat Of Substitutes
5.13.3 Bargaining Power Of Buyers
5.13.4 Bargaining Power Of Suppliers
5.13.5 Intensity Of Competitive Rivalry
5.14 Key Stakeholders & Buying Criteria
5.14.1 Key Stakeholders In Buying Process
5.14.2 Role Of Stakeholders In Buying Process
5.14.3 Buying Criteria For Mice Model Market
5.15 Investment & Funding Scenario
5.16 Impact Of Generative Ai On Mice Model Market
5.16.1 Ai-use Cases
5.16.2 Key Companies Implementing Ai
5.17 Case Studies
5.17.1 Case Study 1: Aav Gene Editing In Cyagen Ldlr Mutant Mice Ameliorates Atherosclerosis
5.17.2 Case Study 2: Metabolic Effects Of Semaglutide & Tirzepatide In Diet-induced Obese (Dio) Micebac
5.17.3 Case Study 3: Targeting Natural Killer Cell Activity With Humanized Nsg-il15 Mouse Model
5.18 Trump Tariff Impact On Mice Model Market
5.18.1 Key Tariff Rates
5.18.2 Price Impact Analysis
5.18.3 Key Impact On Various Regions
5.18.3.1 Us
5.18.3.2 Europe
5.18.3.3 Asia Pacific
5.18.3.4 Rest Of The World
5.18.4 End-use Industry Impact
5.18.4.1 Pharmaceutical & Biotechnology Companies
5.18.4.2 Cros & Cdmos
5.18.4.3 Academic & Research Institutes
6 Mice Model Market, By Model Type & Service
6.1 Introduction
6.2 Model Type
6.2.1 Inbred Mice
6.2.1.1 High Utilization Across Research Applications To Propel Market
6.2.2 Genetically Engineered Mice
6.2.2.1 Ability To Induce Mutations For Cvd & Cancer Research To Drive Market
6.2.3 Hybrid/Congenic Mice
6.2.3.1 Growing Focus On Biomedical Research To Boost Demand
6.2.4 Outbred Mice
6.2.4.1 Genetic Diversity Benefits To Support Market Growth
6.3 Services
6.3.1 Breeding Services
6.3.1.1 Customization Of Models For Specific Research Applications To Boost Demand
6.3.2 Cryopreservation Services
6.3.2.1 Rising Focus On Preservation Of Novel Mice Models To Propel Market
6.3.3 Rederivation Services
6.3.3.1 Stringent Quality Assurance Standards To Fuel Market
6.3.4 Quarantine Services
6.3.4.1 Rising Demand For Germ-free Mice To Support Market Growth
6.3.5 Other Services
7 Mice Model Market, By Technology
7.1 Introduction
7.2 Crispr/Cas9
7.2.1 Advantages Such As Simplified Design And Cost Efficiency To Propel Market
7.3 Microinjections
7.3.1 Low Toxicity And High Success Rate To Drive Market
7.4 Embryonic Stem Cell Injections
7.4.1 Increasing Demand For Targeted Mice Models In Immunological Research To Fuel Market
7.5 Nuclear Transfer Technique
7.5.1 Potential To Produce Identical Mice To Drive Market
7.6 Other Technologies
8 Mice Model Market, By Application
8.1 Introduction
8.2 Drug Discovery & Development
8.2.1 Increasing Number Of Clinical Trials To Propel Market
8.3 Research Applications
8.3.1 Increasing Funding Investments For Cancer Research To Drive Market
8.4 Personalized Medicine
8.4.1 Increasing Preference For Oncology Therapeutics To Support Market Growth
9 Mice Model Market, By Therapeutic Area
9.1 Introduction
9.2 Oncology
9.2.1 Growing Focus On Therapeutic Development To Propel Market
9.3 Metabolic Diseases
9.3.1 Increasing Prevalence Of Endocrine Disorders To Drive Market
9.4 Immunology
9.4.1 Rising Clinical Research Activities For Immunological Disorders To Fuel Market
9.5 Neurology
9.5.1 Increasing Investments In R&D For Cns Diseases To Boost Demand
9.6 Cardiovascular Diseases
9.6.1 Growing Focus On Targeted Treatments For Cvd To Boost Demand
9.7 Other Therapeutic Areas
10 Mice Model Type Market, By End User
10.1 Introduction
10.2 Pharmaceutical & Biotechnology Companies
10.2.1 Rising Expenditure On R&D For Drug Development To Fuel Market
10.3 Contract Research Organizations And Contract Development & Manufacturing Organizations (Cros & Cdmos)
10.3.1 Increasing Outsourcing Of Drug Discovery Services To Drive Market
10.4 Academic & Research Institutes
10.4.1 Increasing Funding Initiatives For Life Sciences R&D To Support Market Growth
11 Mice Model Services Market, By End User
11.1 Introduction
11.2 Pharmaceutical & Biotechnology Companies
11.2.1 Rising Outsourcing Of Preclinical Services To Propel Market
11.3 Contract Development & Manufacturing Organizations (Cdmos)
11.3.1 Development Of Integrated Models And Growth In Biologics To Boost Demand
11.4 Government & Biomedical Research Institutes
11.4.1 Focus On Translational Research Services To Support Market Growth
12 Mice Model Market, By Region
12.1 Introduction
12.2 North America
12.2.1 Macroeconomic Outlook For North America
12.2.2 Us
12.2.2.1 Rising Production Of Monoclonal Antibodies To Fuel Market
12.2.3 Canada
12.2.3.1 Growth In Stem Cell Research Activities To Fuel Market
12.3 Europe
12.3.1 Macroeconomic Outlook For Europe
12.3.2 Germany
12.3.2.1 Growth In Biotechnology Industry To Drive Market
12.3.3 Uk
12.3.3.1 Increasing Focus On Cancer Research To Propel Market
12.3.4 France
12.3.4.1 Rising Investments In Proteomics & Genomics Research To Boost Demand
12.3.5 Italy
12.3.5.1 Growth In Pharmaceutical & Biotechnology Industry To Drive Market
12.3.6 Spain
12.3.6.1 Extensive R&D Pipeline To Fuel Uptake
12.3.7 Rest Of Europe
12.4 Asia Pacific
12.4.1 Macroeconomic Outlook For Asia Pacific
12.4.2 China
12.4.2.1 Favorable Investments In Life Sciences Research To Drive Market
12.4.3 Japan
12.4.3.1 Increasing Focus On Personalized Diagnostics Products To Drive Market
12.4.4 India
12.4.4.1 Favorable Initiatives For Drug Discovery & Development To Boost Market
12.4.5 Australia
12.4.5.1 High Number Of Research Institutes To Favor Market Growth
12.4.6 South Korea
12.4.6.1 Innovation In Health & Biotech Sectors To Support Market Uptake
12.4.7 Rest Of Asia Pacific
12.5 Latin America
12.5.1 Macroeconomic Outlook For Latin America
12.5.2 Brazil
12.5.2.1 Increasing Investments In Biopharmaceutical Research To Fuel Uptake
12.5.3 Mexico
12.5.3.1 Expanding Healthcare Ecosystem To Support Market Growth
12.5.4 Rest Of Latin America
12.6 Middle East
12.6.1 Macroeconomic Outlook In Middle East
12.6.2 Gcc Countries
12.6.2.1 Kingdom Of Saudi Arabia (Ksa)
12.6.2.1.1 Growing Focus On Advancement Of Healthcare Sector To Boost Market
12.6.2.2 United Arab Emirates
12.6.2.2.1 Increasing R&D Activities And Growing Demand For Personalized Medicine To Propel Market
12.6.2.3 Other Gcc Countries
12.6.3 Rest Of Middle East
12.7 Africa
12.7.1 Rising Precision Medicine Initiatives To Support Market Growth
12.7.2 Macroeconomic Outlook For Africa
13 Competitive Landscape
13.1 Overview
13.2 Key Players Strategies/Right To Win
13.2.1 Strategies Adopted By Key Players In Mice Model Market, 2022–2025
13.3 Revenue Share Analysis, 2022−2024
13.4 Market Share Analysis
13.5 Company Evaluation Matrix: Key Players, 2024
13.5.1 Stars
13.5.2 Emerging Leaders
13.5.3 Pervasive Players
13.5.4 Participants
13.5.5 Company Footprint: Key Players, 2024
13.5.5.1 Company Footprint
13.5.5.2 Region Footprint
13.5.5.3 Model Type & Service Footprint
13.5.5.4 Application Footprint
13.5.5.5 Technology Footprint
13.5.5.6 Therapeutic Area Footprint
13.6 Company Evaluation Matrix: Startups/Smes, 2024
13.6.1 Progressive Companies
13.6.2 Responsive Companies
13.6.3 Dynamic Companies
13.6.4 Starting Blocks
13.6.5 Competitive Benchmarking: Startups/Smes, 2024
13.6.5.1 Detailed List Of Key Startups/Sme Players
13.6.5.2 Competitive Benchmarking Of Key Startups/Smes
13.7 Company Valuation & Financial Metrics
13.7.1 Financial Metrics
13.7.2 Company Valuation
13.8 Brand/Product Comparative Analysis
13.8.1 Brand/Product Comparative Analysis For Mice Model Market
13.9 Competitive Scenario
13.9.1 Product/Service Launches
13.9.2 Deals
13.9.3 Expansions
13.9.4 Other Developments
14 Company Profiles
14.1 Key Players
14.1.1 Charles River Laboratories
14.1.1.1 Business Overview
14.1.1.2 Products/Services Offered
14.1.1.3 Recent Developments
14.1.1.3.1 Deals
14.1.1.3.2 Expansions
14.1.1.3.3 Other Developments
14.1.1.4 Mnm View
14.1.1.4.1 Key Strengths
14.1.1.4.2 Strategic Choices
14.1.1.4.3 Weaknesses & Competitive Threats
14.1.2 The Jackson Laboratory
14.1.2.1 Business Overview
14.1.2.2 Products/Services Offered
14.1.2.3 Recent Developments
14.1.2.3.1 Deals
14.1.2.3.2 Expansions
14.1.2.4 Mnm View
14.1.2.4.1 Key Strengths
14.1.2.4.2 Strategic Choices
14.1.2.4.3 Weaknesses & Competitive Threats
14.1.3 Inotiv
14.1.3.1 Business Overview
14.1.3.2 Products/Services Offered
14.1.3.3 Recent Developments
14.1.3.3.1 Deals
14.1.3.3.2 Expansions
14.1.3.4 Mnm View
14.1.3.4.1 Key Strengths
14.1.3.4.2 Strategic Choices
14.1.3.4.3 Weaknesses & Competitive Threats
14.1.4 Jsr Corporation
14.1.4.1 Business Overview
14.1.4.2 Product/Services Offered
14.1.4.3 Recent Developments
14.1.4.3.1 Deals
14.1.4.3.2 Expansions
14.1.4.4 Mnm View
14.1.4.4.1 Key Strengths
14.1.4.4.2 Strategic Choices
14.1.4.4.3 Weaknesses & Competitive Threats
14.1.5 Biocytogen
14.1.5.1 Business Overview
14.1.5.2 Product/Services Offered
14.1.5.3 Recent Developments
14.1.5.3.1 Product/Service Launches
14.1.5.3.2 Deals
14.1.5.3.3 Expansions
14.1.5.4 Mnm View
14.1.5.4.1 Key Strengths
14.1.5.4.2 Strategic Choices
14.1.5.4.3 Weaknesses & Competitive Threats
14.1.6 Shanghai Model Organisms Center, Inc.
14.1.6.1 Business Overview
14.1.6.2 Product/Services Offered
14.1.6.3 Recent Developments
14.1.6.3.1 Deals
14.1.7 Trans Genic Inc.
14.1.7.1 Business Overview
14.1.7.2 Products/Services Offered
14.1.7.3 Recent Developments
14.1.7.3.1 Deals
14.1.8 Harbour Biomed
14.1.8.1 Business Overview
14.1.8.2 Product/Services Offered
14.1.8.3 Recent Developments
14.1.8.3.1 Deals
14.1.8.3.2 Other Developments
14.1.9 Genoway
14.1.9.1 Business Overview
14.1.9.2 Product/Services Offered
14.1.9.3 Recent Developments
14.1.9.3.1 Deals
14.1.10 Gempharmatech
14.1.10.1 Business Overview
14.1.10.2 Product/Services Offered
14.1.10.3 Recent Developments
14.1.10.3.1 Product/Service Launches
14.1.10.3.2 Deals
14.1.10.3.3 Expansions
14.1.11 Cyagen
14.1.11.1 Business Overview
14.1.11.2 Product/Services Offered
14.1.11.3 Recent Developments
14.1.11.3.1 Deals
14.1.12 Ozgene Pty Ltd.
14.1.12.1 Business Overview
14.1.12.2 Products/Services Offered
14.1.12.3 Recent Developments
14.1.12.3.1 Deals
14.1.13 Taconic Biosciences, Inc.
14.1.13.1 Business Overview
14.1.13.2 Products/Services Offered
14.1.13.3 Recent Developments
14.1.13.3.1 Product/Service Launches
14.1.13.3.2 Deals
14.1.13.3.3 Expansions
14.1.14 Transcure Bioservices
14.1.14.1 Business Overview
14.1.14.2 Products/Services Offered
14.1.14.3 Recent Developments
14.1.14.3.1 Deals
14.1.15 Vivo Bio Tech Ltd.
14.1.15.1 Business Overview
14.1.15.2 Product/Services Offered
14.1.16 Ingenious Targeting Laboratory
14.1.16.1 Business Overview
14.1.16.2 Product/Services Offered
14.1.17 Janvier Labs
14.1.17.1 Business Overview
14.1.17.2 Product/Services Offered
14.1.17.3 Recent Developments
14.1.17.3.1 Deals
14.1.18 Champions Oncology, Inc.
14.1.18.1 Business Overview
14.1.18.2 Products Offered
14.1.18.3 Recent Developments
14.1.18.3.1 Deals
14.1.19 Vitalstar Biotechnology Co., Ltd.
14.1.19.1 Business Overview
14.1.19.2 Products Offered
14.2 Other Players
14.2.1 Oncodesign Services
14.2.2 Clea Japan, Inc.
14.2.3 Applied Stemcell
14.2.4 Creative Animodel
14.2.5 Joinn Laboratories (China) Co., Ltd.
14.2.6 Creative Biolabs
14.2.7 Crescendo Biologics Limited
14.2.8 Aragen Life Sciences Ltd.
14.2.9 Polygene
14.2.10 Pharmtest Services
14.2.11 Marshall Bioresources
15 Appendix
15.1 Discussion Guide
15.2 Knowledgestore: Marketsandmarkets’ Subscription Portal
15.3 Customization Options
15.4 Related Reports
15.5 Author Details

Search Inside Report

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us